immunotherapy regimens in dmmr/msi-high metastatic crc
Published 5 years ago • 1.1K plays • Length 4:32Download video MP4
Download video MP3
Similar videos
-
9:25
debate: msi high colon cancer - immunotherapy
-
1:25
neoadjuvant immunotherapy in msi-high colorectal cancer
-
5:49
immunotherapy and msi status in colorectal cancer
-
1:11
remaining questions for the treatment of patients with msi/dmmr mcrc with immunotherapy
-
1:14
current and future trends in immunotherapy for msi-h colorectal cancer
-
1:35
dr. chu on the role of pembrolizumab in dmmr/msi-h mcrc
-
0:35
immunotherapy for msi high colon cancer
-
8:34
relapsed/refractory mcrc: immunotherapy in msi-high tumors
-
5:30
other i-o approaches to metastatic colorectal cancer
-
5:57
significance of msi status and tmb in metastatic crc
-
35:42
immunotherapy in crc | 2023 best of gi cancer conference
-
6:11
immunotherapy in crc
-
9:02
pembrolizumab in msi-h crc tumors
-
1:27
dr. grothey on fda approval of pembrolizumab in msi-high crc
-
0:43
immunotherapy in msi-h/dmmr mcrc: first-line options and dual checkpoint inhibition insights
-
9:24
msi status and immunotherapy in advanced colorectal cancer
-
4:00
immunotherapy combinations in msi and mss mcrc
-
1:04
dr. halfdanarson on the keynote-177 trial in msi-h/dmmr mcrc
-
4:56
asco: pembrolizumab vs. chemotherapy for msi-h metastatic colorectal cancer